Refining early detection of Marburg Virus Disease (MVD) in Rwanda: Leveraging predictive symptom clusters to enhance case definitions

Background: Marburg Virus Disease (MVD) poses a significant global health risk due to its high case fatality rates (24%-88%) and the diagnostic challenges posed by its nonspecific early symptoms, which overlap with other febrile illnesses like malaria. This study analyzed symptom patterns from the 2...

Full description

Saved in:
Bibliographic Details
Main Authors: Olivier Nsekuye, Frederick Ntabana, Hugues Valois Mucunguzi, Ziad El-Khatib, Eric Remera, Lyndah Makayotto, Menelas Nkeshimana, David Turatsinze, Frederic Ntirenganya, Semakula Muhammed, Athanase Rukundo, Brian Chirombo, Richard Muvunyi, Claude Mambo Muvunyi, Pacifique Nizeyimana, Yvan Butera, Sabin Nsanzimana, Edson Rwagasore
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971225001250
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Marburg Virus Disease (MVD) poses a significant global health risk due to its high case fatality rates (24%-88%) and the diagnostic challenges posed by its nonspecific early symptoms, which overlap with other febrile illnesses like malaria. This study analyzed symptom patterns from the 2024 MVD outbreak in Rwanda to refine case definitions and enhance early detection. Methods: A retrospective analysis was conducted of 6613 suspected MVD cases (66 positive, 6547 negative) reported between September 27 and December 20, 2024. Symptom prevalence and predictive value were assessed using multiple logistic regression models with L1 and L2 regularization to identify the most predictive symptoms. Models were validated using 5-fold cross-validation, with performance assessed through ROC analysis and standard accuracy metrics. Results: Fever (78.8%), fatigue (63.6%), and headache (57.6%) were identified as the most common early symptoms, while hemorrhagic signs were rare (3.0%). The model achieved high accuracy (99.04%) and an area under the receiver operating characteristic curve of 0.824, identifying fever, fatigue, nausea/vomiting, joint pain, and sore throat as key predictors. Conclusion: Early symptom clusters, especially constitutional and gastrointestinal signs outperformed hemorrhagic symptoms for MVD detection. Findings challenge current case definitions, emphasizing the need for revised public health messaging and healthcare worker training. Integrating symptom-based models into surveillance could enhance detection, especially in resource-limited settings.
ISSN:1201-9712